About IO Biotech, Inc. Common Stock
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Market Cap
$0.08B
Employees
68
Listed Since
November 5, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.iobiotech.comPhone
(457) 070-2980
Headquarters
OLE MAALOES VEH 3
COPENHAGEN, G7 2200
CIK
0001865494